The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. (Q51645410)
Jump to navigation
Jump to search
scientific article published in January 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. |
scientific article published in January 1994 |
Statements
The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. (English)
1 reference
Bartlett SE
1 reference
Cramond T
1 reference
1 January 1994
1 reference
54
1 reference
10
1 reference
687-694
1 reference